Se-atlas-cartographic representation of experts for rare diseases by Holger Storf et al.
POSTER PRESENTATION Open Access
Se-atlas-cartographic representation of experts for
rare diseases
Holger Storf1*, Tobias Hartz1, Wulf Pfeiffer1, Kathrin Rommel2, Mareike Derks2, Elisabeth Nyoungui2,
Joerg Schmidtke2, Holm Graessner3, Mirjam Knoell3, Thomas Wagner4, Frank Ueckert1
From 7th European Conference on Rare Diseases and Orphan Products (ECRD 2014)
Motivation
Numerous highly specialized facilities for the diagnosis
and treatment of rare diseases exist in Germany, but it is
challenging to present them adequately. Searching in the
internet is a common way for patients to find medical
information or appropriate clinical experts [1]. Existing
services and databases such as Orphanet already offer
good contact information to expert centers. A core chal-
lenge is to keep the data up to date and to ensure the
expertise of the listed centers.
Aim of the project
The project’s aim is to visualize and present the known
expert centers in an innovative way and to help complet-
ing existing data bases. The representation is realized in
an interactive map and in a list format. Stakeholders of the
information system are patients and their relatives,
doctors, non-medical personnel and the general public.
The basis for the underlying data set of the eligible facil-
ities is provided by the project partner Orphanet Germany.
The project’s primary goals are to consistently increase the
data set and to ensure its quality.
Conception
In se-atlas general information about the expert centers
like name, address, special consultation hours, etc. are
stored. To find the relevant centers, they are tagged
additionally with the treated diagnoses (by using the
Orphanet classification and ICD-10). The decision
which centers will be listed or not will be made by an
editorial team based on the so-called NAMSE criteria
proposed in the German national plan by the Joint
Declaration and Agreement on the Establishment of the
National Action League for People with Rare Diseases
(NAMSE). Both, centers for rare diseases and patient
organizations will be allowed to grant affirmations of
quality. The conception allows for individual views of
the cartographic visualization to be included on other
web pages, e.g. those of patient organizations.
Realization and test
At present, the system is implemented in a prototypical
way and accessible for registered persons only. The core
functions are realized and the Orphanet classification is
included. The next steps are to include the Orphanet
data base of expert centres and contact the centers for
rare diseases for including them.
Schedule
Se-atlas started in June 2013 and is scheduled to run for
two years. The public release of the official version is
planned for January 2015.
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